Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer

The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma

(2018) Jiaxin Wen et al.   JOURNAL OF SURGICAL ONCOLOGY

Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection

(2017) Ryuma Tokunaga et al.   International Journal of Clinical Oncology

Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study

(2017) Miranda M Fidler et al.   LANCET ONCOLOGY

Preoperative patient-related factors associated with prognosis after esophagectomy for esophageal cancer

(2017) Hiroyuki Kitagawa et al.   Esophagus

Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma

(2016) Fei Ji et al.   MEDICINE

Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer

(2016) Tsutomu Namikawa et al.   ONCOLOGY

The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma

(2015) Xiao-li Wei et al.   TUMOR BIOLOGY

The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib

(2015) Luca Faloppi et al.   Oncotarget

Model based on γ-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis

(2014) Xin-Sen Xu   WORLD JOURNAL OF GASTROENTEROLOGY

Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value

(2014) Felix Berlth   WORLD JOURNAL OF GASTROENTEROLOGY

Alkaline Phosphatase ALPPL-2 Is a Novel Pancreatic Carcinoma-Associated Protein

(2013) P. Dua et al.   CANCER RESEARCH

Glasgow Prognostic Score as a Prognostic Factor in Patients Undergoing Curative Surgery for Colorectal Cancer

(2013) Kiichi Sugimoto et al.   DIGESTIVE SURGERY

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry

(2012) Atsushi Nashimoto et al.   Gastric Cancer

Metabolic reprogramming of the tumor

(2012) L M R Ferreira et al.   ONCOGENE

Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma

(2012) Guo Li et al.   Chinese Journal of Cancer

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

(2011) M J Proctor et al.   BRITISH JOURNAL OF CANCER

Lactate: A Metabolic Key Player in Cancer

(2011) F. Hirschhaeuser et al.   CANCER RESEARCH

Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?

(2011) Ming-Chin Yu et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

(2009) Narikazu Boku et al.   LANCET ONCOLOGY

Lactate Dehydrogenase-5 (LDH-5) Expression in Human Gastric Cancer: Association with Hypoxia-Inducible Factor (HIF-1α) Pathway, Angiogenic Factors Production and Poor Prognosis

(2008) Yanislav Kolev et al.   ANNALS OF SURGICAL ONCOLOGY

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY